Clinical Trials Browser

Phase 2 × Osteosarcoma × apatinib × Clear all

NCT03742193 2023-11-01

PROACH

Phase 2 Unknown

Osteosarcoma

NCT04351308 2020-05-19

MAPAC

Phase 2 Unknown

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT03163381 2017-05-23

Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.

Phase 2 Unknown

Osteosarcoma